APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Plant is part of the company's CAD $30 million capital investment in the site
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Subscribe To Our Newsletter & Stay Updated
